Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Carles

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 26, 2000
Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancerJ Bellmunt, V Guillem, L Paz-Ares, et al.
Acta Oncologica (Stockholm, Sweden)|July 11, 1998
Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patientsJ Carles, M Domenech, A Gelabert-Mas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 7, 2018
Correction to: SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)J Cassinello, J Á Arranz, J M Piulats, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2010
Eccrine porocarcinoma presenting with scrotal lymphedema: a case report and review of systemic treatmentJ Perez-Garcia, R Morales, C M Valverde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
E400P in advanced seminoma of good prognosis according to the international germ cell cancer collaborative group (IGCCCG) classification: the Spanish Germ Cell Cancer Group experienceJ A Arranz Arija, X García del Muro, J Gumà, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 15, 2017
SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)J Cassinello, J Á Arranz, J M Piulats, et al.
Actas Urologicas Espanolas|September 25, 2012
[Recomendations on the management of controversies in advanced castrate-resistant prostate cancer]J M Cózar, E Solsona, J Morote, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancerJ Carles, E Esteban, M Climent, et al.
Medicina Intensiva|November 29, 2021
Clinical risk factors for early mortality in patients with community-acquired septic shock. The importance of adequate source controlJ Vallés, E Diaz, J Carles Oliva, et al.
Journal of Surgical Oncology|March 1, 1994
Central venous brachial catheter (P.A.S. Port TM) and catheter scanning system (Cath-Finder TM)M C Carré, J M López Vega, J Carles, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|July 26, 2000
Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancerJ Bellmunt, V Guillem, L Paz-Ares, et al.
Acta Oncologica (Stockholm, Sweden)|July 11, 1998
Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patientsJ Carles, M Domenech, A Gelabert-Mas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 7, 2018
Correction to: SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)J Cassinello, J Á Arranz, J M Piulats, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2010
Eccrine porocarcinoma presenting with scrotal lymphedema: a case report and review of systemic treatmentJ Perez-Garcia, R Morales, C M Valverde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
E400P in advanced seminoma of good prognosis according to the international germ cell cancer collaborative group (IGCCCG) classification: the Spanish Germ Cell Cancer Group experienceJ A Arranz Arija, X García del Muro, J Gumà, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 15, 2017
SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)J Cassinello, J Á Arranz, J M Piulats, et al.
Actas Urologicas Espanolas|September 25, 2012
[Recomendations on the management of controversies in advanced castrate-resistant prostate cancer]J M Cózar, E Solsona, J Morote, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancerJ Carles, E Esteban, M Climent, et al.
Medicina Intensiva|November 29, 2021
Clinical risk factors for early mortality in patients with community-acquired septic shock. The importance of adequate source controlJ Vallés, E Diaz, J Carles Oliva, et al.
Journal of Surgical Oncology|March 1, 1994
Central venous brachial catheter (P.A.S. Port TM) and catheter scanning system (Cath-Finder TM)M C Carré, J M López Vega, J Carles, et al.
Pageof 14